Dokumentuaren aipamena
APA (7th ed.) Zitazioa
Malinda Itchins, B., Shirley Liang, B., Chris Brown, M., Tristan Barnes, B., Gavin Marx, B., Venessa Chin, M., . . . Nick Pavlakis, B. (2024). ALKTERNATE: A Pilot Study Alternating Lorlatinib With Crizotinib in ALK-Positive NSCLC With Prior ALK Inhibitor Resistance. Elsevier.
Ondo kopiatu da
Kopiatzeak huts egin du
Chicago Style (17th ed.) Zitazioa
Malinda Itchins, BMedSci, et al. ALKTERNATE: A Pilot Study Alternating Lorlatinib With Crizotinib in ALK-Positive NSCLC With Prior ALK Inhibitor Resistance. Elsevier, 2024.
Ondo kopiatu da
Kopiatzeak huts egin du
MLA (9th ed.) Zitazioa
Malinda Itchins, BMedSci, et al. ALKTERNATE: A Pilot Study Alternating Lorlatinib With Crizotinib in ALK-Positive NSCLC With Prior ALK Inhibitor Resistance. Elsevier, 2024.
Ondo kopiatu da
Kopiatzeak huts egin du
Kontuz: berrikusi erreferentzia hauek erabili aurretik.